Investors

Webcast ImageWebcast - Replay
OraSure Technologies 2016 Analyst Day
11/29/16 at 10:00 a.m. ET
OraSure Technologies 2016 Analyst Day
Tuesday, November 29, 2016 10:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians’ offices, and commercial and industrial entities.
More>>
Featured Reports
Fact Sheet - PDF Fact Sheet
2015 Annual Report on Form 10-K - PDF 2015 Annual Report on Form 10-K
OSUR (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$8.37
Change (%) Stock is Down 0.18 (2.11%)
Volume333,091
Data as of 12/02/16 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore >>
DateTitle 
11/29/16OraSure to Implement $18 Million Product Supply Contract From Foreign Government for HCV Elimination Program
BETHLEHEM, Pa., Nov. 29, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, announced today that it will begin fulfilling a contract to supply a foreign government with $18 million of product, primarily to support a nationwide hepatitis C (HCV) testing and treatment program with the goal of eliminating HCV infection across the country by 2020. The contract calls for the purchase of $16 million of Ora... 
Printer Friendly Version
11/29/16Helix Selects DNA Genotek’s Oragene® Collection Device and GenoFIND Fulfillment Services for Genetic Discovery Applications
- Oragene®●Dx saliva collection kits to provide reliable DNA samples for Helix - BETHLEHEM, Pa., Nov. 29, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, announced today that Helix, the personal genomics company, has selected the Oragene®Ÿ●Dx device to provide reliable self-collection of DNA samples to be used in a genetic information discovery service offered by Helix for consumers.  OraSure’s whol... 
Printer Friendly Version
11/21/16OraSure Technologies to Host Analyst Day
BETHLEHEM, Pa., Nov. 21, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a market leader in point-of-care diagnostic tests and specimen collection devices, today announced that it will host an Analyst Day meeting on Tuesday, November 29, 2016 in New York City, New York, at the NASDAQ MarketSite at Times Square.  Presentations by OraSure’s senior executive team are scheduled to begin at 10:00 a.m. (Eastern Time) and conclude by 1:00 p.m. (Eastern Time) and will cover various ... 
Printer Friendly Version
11/15/16OraSure Technologies Appoints Stephen S. Tang, Ph.D. as Chairman of the Board of Directors
BETHLEHEM, Pa., Nov. 15, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced the appointment of Stephen S. Tang, Ph.D., as Chairman of the Company’s Board of Directors (the “Board”), effective November 14, 2016. Dr. Tang has been a Board member since April 2011, has served as Chairman of the Compensation Committee since May 2014 and is also a member of the Nominating and Corporate Governa... 
Printer Friendly Version
Upcoming EventsMore >>
DateTitle
05/16/17 10:00 a.m. ET
OraSure Technologies, Inc. 2017 Annual Meeting of Stockholders
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources



Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | IR Contacts IR Contacts | Financial Tear Sheet Financial Tear Sheet